Suppr超能文献

甲状腺毒症患者对格列本脲的血浆胰岛素反应。

Plasma insulin response to glibornuride in thyrotoxicosis.

作者信息

Federspil G, Zaccaria M, Casara D, Sicolo N, Scandellari C

出版信息

Diabete Metab. 1976 Mar;2(1):27-31.

PMID:136374
Abstract

The glycemic and insulinemic response to i.v. glibornuride injection has been studied in a group of 8 euthyroid subjects and in a group of 9 thyrotoxic patients before and after reserpine treatment. In thyrotoxic patients sulfonylurea did not lower blood glucose more than in normal subjects. The plasma insulin response, however, was definitely higher than that of the controls in the first few minutes; after the 20th minute, however, levels of insulinemia were not appreciably different in the two groups. Insulin delivery rate was greater in hyperthyroid patients than in the controls. Administration of reserpine for a few days, did not modify either insulin response or blood glucose fall in thyrotoxic patients.

摘要

在一组8名甲状腺功能正常的受试者以及一组9名甲状腺毒症患者中,研究了静脉注射格列本脲后的血糖和胰岛素反应,这些甲状腺毒症患者在利血平治疗前后进行了观察。在甲状腺毒症患者中,磺脲类药物降低血糖的效果并不比正常受试者更明显。然而,在最初几分钟内,血浆胰岛素反应肯定高于对照组;但在第20分钟后,两组的胰岛素血症水平没有明显差异。甲状腺功能亢进患者的胰岛素释放率高于对照组。对甲状腺毒症患者给予利血平数天,并未改变胰岛素反应或血糖下降情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验